We are live on ! Find out more
PKBOW

Peak Bio, Inc. Warrant
PKBOW

Delisted

PKBOW was delisted on the 5th of January, 2023.

17 hedge funds and large institutions have $701K invested in Peak Bio, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 1617 (+1)

26% less capital invested

Capital invested by funds: $948K → $701K (-$247K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

PKBOW Hedge Fund Activity: Q2 2022 in Review

17 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q2 2022, worth a combined $701K — down 26% from $948K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PKBOW positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Yakira Capital Management, opening a new position worth an estimated $7.98K. The largest seller was Picton Mahoney Asset Management, exiting entirely with an estimated $9K sold.

  • 17 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q2 2022, up from 16 in Q1 2022.
  • Funds reported $701K of Peak Bio, Inc. Warrant stock for Q2 2022, down 26% quarter-over-quarter.
  • 3 funds opened new Peak Bio, Inc. Warrant positions in Q2 2022 and 2 closed out, a net change of +1 holder.
  • The largest Peak Bio, Inc. Warrant buyer in Q2 2022 was Yakira Capital Management, an estimated $7.98K added.
  • The largest Peak Bio, Inc. Warrant seller in Q2 2022 was Picton Mahoney Asset Management, an estimated $9K sold.

Based on aggregated 13F filings for Q2 2022.